[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Nurexone Biologic Inc (NRXBF)

Nurexone Biologic Inc (NRXBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 32,068
  • Shares Outstanding, K 94,458
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,380 K
  • EBIT $ -6 M
  • EBITDA $ -6 M
  • 60-Month Beta 0.35
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 17.56
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings $-0.02 on 06/01/26
  • Next Earnings Date 08/26/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3067 +10.69%
on 08/04/26
0.5101 -33.44%
on 08/21/26
+0.0393 (+13.09%)
since 07/28/26
3-Month
0.3002 +13.09%
on 07/28/26
0.5101 -33.44%
on 08/21/26
-0.1256 (-27.00%)
since 05/28/26
52-Week
0.3002 +13.09%
on 07/28/26
0.8000 -57.56%
on 09/16/25
-0.2444 (-41.86%)
since 08/28/25

Most Recent Stories

More News
NurExone Biologic Inc. Announces Second Quarter 2026 Financial Results

TORONTO and HAIFA, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc.  (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a biotechnology company developing...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Biologic Inc. Announces Second Quarter 2026 Financial Results

TORONTO and HAIFA, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”),...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Biologic Inc. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference

TORONTO and HAIFA, Israel, Aug. 28, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a biotechnology company developing...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Biologic Inc. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference

TORONTO and HAIFA, Israel, Aug. 28, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”),...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Announces Annual General and Special Meeting to Consider Share Consolidation in Support of U.S. Capital Markets Strategy

Proposed share consolidation of up to 30:1 intended to support potential U.S. exchange listing and broaden investor appeal TORONTO and HAIFA, Israel, Aug. 21, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Announces Annual General and Special Meeting to Consider Share Consolidation in Support of U.S. Capital Markets Strategy

Proposed share consolidation of up to 30:1 intended to support potential U.S. exchange listing and broaden investor appeal

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Announces Closing of C$1,066,078 Private Placement

TORONTO, and HAIFA, Israel, Aug. 21, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a biopharmaceutical company developing...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Announces Closing of C$1,066,078 Private Placement

TORONTO, and HAIFA, Israel, Aug. 21, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”),...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Reports New Preclinical Tissue-Analysis Data Supporting Potential Neuroprotective Effect of ExoPTEN in Acute Spinal Cord Injury Animal Model

TORONTO and HAIFA, Israel, Aug. 14, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (" NurExone " or the " Company ") (TSXV: NRX, OTCQB: NRXBF, FSE: J90), a biotechnology company developing exosome-based...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)
NurExone Reports New Preclinical Tissue-Analysis Data Supporting Potential Neuroprotective Effect of ExoPTEN in Acute Spinal Cord Injury Animal Model

Tissue analysis showed significantly higher numbers of myelin-positive cells in ExoPTEN-treated animals compared with controls, providing additional preclinical biological support for previously reported...

NRX.VN : 0.540 (+9.09%)
NRXBF : 0.3395 (-11.10%)

Business Summary

NurExone Biologic Inc. is a pharmaceutical company which involved in developing a platform for biologically guided exosome-based therapies to be delivered, non-invasively, to patients who have suffered Central Nervous System injuries. The Company's principal product includes ExoPTEN. NurExone Biologic...

See More

Key Turning Points

3rd Resistance Point 0.3395
2nd Resistance Point 0.3395
1st Resistance Point 0.3395
Last Price 0.3395
1st Support Level 0.3395
2nd Support Level 0.3395
3rd Support Level 0.3395

See More

52-Week High 0.8000
Fibonacci 61.8% 0.6091
Fibonacci 50% 0.5501
Fibonacci 38.2% 0.4911
Last Price 0.3395
52-Week Low 0.3002

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.